PROfiling the risk of Severe Adverse Events during sequencing therapies in patients with multiple sclerosis: an observational cohort analysis based on Italian Multiple Sclerosis Registry.
Fondazione Italiana Sclerosi Multipla – FISM – Ente del Terzo Settore/ETS e, in forma abbreviata, FISM ETS. Iscrizione al RUNTS Rep. N° 89695 - Fondazione con Riconoscimento di Personalità Giuridica - C.F. 95051730109
PROfiling the risk of Severe Adverse Events during sequencing therapies in patients with multiple sclerosis: an observational cohort analysis based on Italian Multiple Sclerosis Registry.
---
---
---